6-K

CURRENT REPORT OF FOREIGN ISSUER

Company: CytoMed Therapeutics Ltd
Filed: April 28, 2025
Period of Report: April 28, 2025
Accession Number: 0001641172-25-006460

View Document ↗ View on SEC.gov ↗